Stability of an extemporaneously compounded minoxidil oral suspension

被引:6
作者
Song, Yunmei [1 ]
Chin, Zen Whey [1 ]
Ellis, David [2 ]
Lwin, Ei Mon Phyo [1 ]
Turner, Sean [2 ]
Williams, Desmond [1 ]
Garg, Sanjay [3 ]
机构
[1] Univ South Australia, Sch Pharm & Med Sci, Ctr Pharmaceut Innovat & Dev, Adelaide, SA, Australia
[2] Womens & Childrens Hosp, Dept Pharm, Adelaide, SA, Australia
[3] Univ South Australia, Sch Pharm & Med Sci, Adelaide, SA, Australia
关键词
chromatography; compounding; liquid; minoxidil; stability; storage; suspensions; HYPERTENSIVE CHILDREN; MEDICINES; THERAPY;
D O I
10.2146/ajhp160457
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Purpose. Results of a study to determine the stability of an extemporaneously compounded minoxidil oral suspension under various temperature and stress conditions are reported. Methods. Commercially available minoxidil tablets (10 mg) were crushed to a fine powder, and predetermined amounts of 2 suspending vehicles were added to produce a 1-mg/mL suspension, which was stored in glass bottles at room temperature (25 +/- 2 degrees C) or in a refrigerator (4 +/- 2 degrees C). To simulate daily patient use, 5 days weekly 1 bottle of the suspension was removed from refrigerated storage and shaken and 0.5 mL of the contents discarded. At each specified time point, samples were analyzed in duplicate (n = 6 for each test condition) using a validated high-performance liquid chromatography method. Samples were visually observed and their pH measured at each time point. Microbiological studies were performed on day 0 and at week 24. Results. The mean percentage of initial minoxidil concentration remaining in all refrigerated samples exceeded 90% throughout the 24-week study, with no change in appearance, pH, microbial activity, odor, or redispersibility. During storage at room temperature, the suspension exhibited a color change at week 4, with slight sedimentation after 6 weeks, although minoxidil recovery exceeded 90% for 10 weeks. Conclusion. An extemporaneously compounded minoxidil oral suspension was stable for 24 weeks when stored in a refrigerator. This suspension can be used for up to 3 weeks when stored at room temperature.
引用
收藏
页码:309 / 315
页数:7
相关论文
共 50 条
[21]   Stability of an extemporaneously prepared tadalafil suspension [J].
Pettit, Rebecca S. ;
Johnson, Cary E. ;
Caruthers, Regine L. .
AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY, 2012, 69 (07) :592-594
[22]   Stability of codeine phosphate in an extemporaneously compounded syrup [J].
Dentinger, Paul J. ;
Swenson, Chad F. .
AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY, 2007, 64 (24) :2569-2573
[23]   Stability of an extemporaneously compounded levothyroxine sodium oral liquid [J].
Boulton, DW ;
Fawcett, JP ;
Woods, DJ .
AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY, 1996, 53 (10) :1157-1161
[24]   Stability of extemporaneously prepared moxifloxacin oral suspensions [J].
Hutchinson, David J. ;
Johnson, Cary E. ;
Klein, Kristin C. .
AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY, 2009, 66 (07) :665-667
[25]   Stability of extemporaneously prepared rifaximin oral suspensions [J].
Cober, Mary Petrea ;
Johnson, Cary E. ;
Lee, Jordan ;
Currie, Kenne .
AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY, 2010, 67 (04) :287-289
[26]   Stability of extemporaneously prepared glycopyrrolate oral suspensions [J].
Cober, Mary Petrea ;
Johnson, Cary E. ;
Sudekum, David ;
Penprase, Kimberly .
AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY, 2011, 68 (09) :843-845
[27]   Stability of extemporaneously prepared oxandrolone oral suspensions [J].
Johnson, Cary E. ;
Cober, Mary Petrea ;
Hawkins, Katherine A. ;
Julian, Justin D. .
AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY, 2011, 68 (06) :519-521
[28]   STABILITY OF CYCLOSPORINE IN AN EXTEMPORANEOUSLY COMPOUNDED PASTE [J].
GHNASSIA, LT ;
YAU, DF ;
KAYE, KI ;
DUGGIN, GG .
AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY, 1995, 52 (20) :2204-2207
[29]   Stability of compounded thioguanine oral suspensions [J].
Aliabadi, Hamidreza Montazeri ;
Romanick, Marcel ;
Somayaji, Vishwa ;
Mahdipoor, Parvin ;
Lavasanifar, Afsaneh .
AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY, 2011, 68 (10) :900-908
[30]   Stability of acetazolamide, allopurinol, azathioprine, clonazepam, and flucytosine in extemporaneously compounded oral liquids [J].
Allen, LV ;
Erickson, MA .
AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY, 1996, 53 (16) :1944-1949